The effect of cardiac remote ischemic preconditioning (IRPC) on the release of cardiac troponin I after elective percutaneous coronary intervention (PCI)

The effect of cardiac remote ischemic preconditioning (IRPC) on the release of cardiac troponin I after elective percutaneous coronary intervention (PCI) in outpatients admitted to the angiography ward

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180306038978N1

Enrollment

240

Registered

2019-05-28

Start date

2018-10-06

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic heart disease. Acute ischemic heart disease, unspecified

Interventions

Intervention 1: Intervention group: An hour before percutaneous coronary intervention a blood pressure cuff will be placed around the non-dominant arm of the patients, then it will be inflated up to 2

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age of 18 years or older Stable coronary artery disease Requirement of elective PCI

Exclusion criteria

Exclusion criteria: Emergency PCI Renal dysfucntion High cardiac troponin levels before PCI Women of childbearing age Use of Nicorandil or Glibenclamide Severe comorbidities (terminal illnesses, advanced cancers with low life expectancy, renal failure, hepatic failure, rheumatic diseases)

Design outcomes

Primary

Measure	Time frame
Cardiac troponin I. Timepoint: Cardiac troponin I is measured right before and 18 hours after percutaneous coronary intervention. Method of measurement: Quantitative measurement of cardiac troponin I using enzymatic method.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShoeib Paskhandi

Bandare-abbas University of Medical Sciences

hums@hums.ac.ir+98 76 3371 0370

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 21, 2026